Home Compliance Teva Pharmaceuticals Challenges Government Request for Advisory Rulings in FCA Case ComplianceFCANews Teva Pharmaceuticals Challenges Government Request for Advisory Rulings in FCA Case June 6, 2023 9 Share FacebookLinkedinTwitter OpturaDesign | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Off-Label Prescriptions Are Not Labeled as False When Relator Does Not Plead False Certification Compliance Keeping the Lodestar Local — Mississippi Court Refuses to Apply D.C. Rates for FCA Fee Award Compliance Fraud-on-the-FDA is Not False for the FCA